Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: São Paulo Advanced School of Comparative Oncology: Abstracts

Open Access Open Badges Poster presentation

Evaluation of myeloid metaplasia in canine mixed mammary tumors

Cecilia B Campos1, Patricia A Auler1, Angelica C Bertagnolli1, Enio Ferreira1, Gustavo M Ribeiro2, Ana PM Dias1, Liliane C Campos1 and Geovanni D Cassali1*

Author Affiliations

1 Department of General Pathology, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil

2 Department of Medical Sciences, Federal University of Ouro Preto (UFOP), Ouro Preto, Brazil

For all author emails, please log on.

BMC Proceedings 2013, 7(Suppl 2):P13  doi:10.1186/1753-6561-7-S2-P13

The electronic version of this article is the complete one and can be found online at:

Published:4 April 2013

© 2013 Campos et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Mixed tumors are among the most frequent mammary neoplasms in female dogs. Some of these tumors present bone marrow associated with the newly formed osseous tissue, characteristic of myeloid metaplasia. Our aims were to evaluate the occurrence of these lesions in a series of mixed tumors, and to determine tumor histomorphological characteristics.

Materials and methods

384 mammary mixed tumors from 289 animals have been reviewed. Lesions were classified according to the presence of osseous metaplasia associated with myeloid metaplasia or extramedullary hematopoiesis. Myeloid metaplasia characterization was determined from the morphological characteristics and organization of cells and adjacent tissues.


The 384 cases included 206 benign and 178 carcinomas in mixed tumors. Osseous metaplasia was present in 16.1% and calcified areas exclusively in 3.1% of lesions. Among all osseous metaplasia, 33.9% presented some type of extramedullary hematopoiesis, of which 71.4% were classified as myeloid metaplasia and 28.6% as extramedullary hematopoiesis. Myeloid metaplasia cases consisted of 67% benign mixed tumors and 33% carcinomas in mixed tumors. Myeloid metaplasia was observed in 24% of mixed tumors containing osseous metaplasia and in 4% of all mixed tumors analyzed.


Despite these results and considering the low frequency of this lesion, additional studies are needed to understand the implications of myeloid metaplasia in canine mammary mixed tumors.

Financial support